Glaxosmithkline Biologicals Sa

Novartis Ag

Novartis Vaccines & Diagnostics, Gmbh

Novartis Vaccines and Diagnostics Srl

J. Craig Venter Institute

Marirosa Mora

Vega Masignani

Maria Scarselli

Cesira Galeotti

Vincenzo Scarlato

Guido Grandi

Rino Rappuoli

Mariagrazia Pizza

Claire M Fraser

Herve Tettelin

Giulio Ratti

Erin Hickey

J Craig Venter

Jeremy Petersen

Guilio Ratti

Claudio Donati

Jeremy D Peterson

Craig Ventor

Hervé Tettelin

The invention provides proteins fromincluding amino acid sequences and the corresponding nucleotide sequences. The proteins are useful for vaccines, immunogenic compositions, diagnostics, enzymatic studies and also as targets for antibiotics.

[object Object]

The invention provides proteins from, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.

This invention provides, among other things, proteins, polypeptides, and fragments thereof, derived from the bacteriaB. Also provided are nucleic acids encoding for such proteins, polypeptides, and/or fragments, as well as nucleic acids complementary thereto e.g., antisense nucleic acids). Additionally, this invention provides antibodies which bind to the proteins, polypeptides, and/or fragments. This invention further provides expression vectors useful for making the proteins, polypeptides, and/or fragments, as well as host cells transformed with such vectors. This invention also provides compositions of the proteins, polypeptides, fragments, and/or nucleic acids, for use as vaccines, diagnostic reagents, immunogenic compositions, and the like. Methods of making the compositions and methods of treatment with the compositions are also provided. This invention also provides methods of detecting the proteins, polypeptides, fragments, and/or nucleic acids.

Neisserial antigenic peptides

The invention provides proteins from, including amino acid sequences and corresponding nucleotide sequences. The proteins are useful for vaccines, immunogenic compositions, diagnostics, enzymatic studies, and as targets for antibiotics.

WO99/36544 discloses a large number of proteins from. The present invention relates to fragments of those proteins which comprise at least one antigenic determinant. Homologous sequences and proteins comprising these fragments are also disclosed.

Antigenic meningococcal peptides

Growing community of inventors

Siena, Italy

Marirosa Mora